Classification of Stages 1,2,3 and Preplus, Plus disease of ROP using MultiCNN_LSTM classifier

Ranjana Agrawal1, Sucheta Kulkarni2, Madan Deshpande2

  • 1Dr. Vishwanath Karad MIT World Peace University, Pune, India.

Methodsx
|February 13, 2025
PubMed

Insights

This study introduces an explainable AI system for detecting retinopathy of prematurity (ROP) in premature infants. The system accurately classifies ROP stages and identifies Plus disease, crucial for preventing infant blindness.

Area of Science:

  • Ophthalmology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Retinopathy of prematurity (ROP) is a leading cause of blindness in premature infants.
  • Accurate staging and identification of Plus disease are critical for timely ROP treatment.
  • Current diagnostic methods rely on manual retinal image examination, which can be subjective and time-consuming.

Purpose of the Study:

  • To develop and evaluate an explainable automated system for ROP screening.
  • To improve the accuracy of classifying ROP stages (1-3) and detecting Pre-plus/Plus disease.
  • To leverage deep learning models for enhanced ROP diagnosis from retinal fundus images.

Main Methods:

  • Utilized multiple Convolutional Neural Networks (CNNs) for feature extraction from retinal images.
  • Employed Long Short-Term Memory (LSTM) networks for image classification.
  • Developed and used the Cropped STAGE and HVDROPDB-PLUS datasets, including RetCam and Neo images.

Main Results:

  • The proposed MultiCNN-LSTM networks demonstrated superior performance compared to individual CNNs and CNN-LSTM models.
  • Achieved higher accuracy and F1 scores in classifying ROP stages and identifying Plus disease.
  • The system provides explainable classifications for ROP screening.

Conclusions:

  • The developed explainable AI system shows significant potential for accurate and efficient ROP screening.
  • This automated approach can aid ophthalmologists in early detection and treatment of ROP.
  • Further validation on larger datasets is warranted to confirm clinical utility.